Market Overview

Benzinga's Top Upgrades, Downgrades For May 5, 2017

Share:

Top Upgrades

  • Analysts at Bank of America upgraded Zynga Inc (NASDAQ: ZNGA) from Underperform to Neutral. Zynga shares rose 11.27 percent to $3.16 in pre-market trading.
  • Analysts at Cantor Fitzgerald upgraded Web.com Group Inc (NASDAQ: WEB) from Hold to Overweight. Web.com shares dropped 0.51 percent to $19.50 in after-hours trading.
  • Analysts at Wells Fargo upgraded Hess Corp. (NYSE: HES) from Market Perform to Outperform. Hess shares fell 2.20 percent to close at $45.84 on Thursday.
  • Guggenheim upgraded IAC/InterActiveCorp (NASDAQ: IAC) from Neutral to Buy. IAC/InterActive shares climbed 1.64 percent to $99.40 in pre-market trading.
  • Macquarie upgraded Verisk Analytics, Inc. (NASDAQ: VRSK) from Neutral to Outperform. Verisk Analytics shares rose 0.50 percent to $78.40 in pre-market trading.
  • Raymond James upgraded Targa Resources Corp (NYSE: TRGP) from Outperform to Strong Buy. Targa Resources shares rose 0.49 percent to $49.15 in pre-market trading.
  • Canaccord Genuity upgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from Hold to Buy. Regeneron Pharmaceuticals shares rose 0.85 percent to $438.00 in pre-market trading.
  • Analysts at UBS upgraded CF Industries Holdings, Inc. (NYSE: CF) from Neutral to Buy. CF Industries shares rose 0.66 percent to $27.25 in pre-market trading.
  • Oppenheimer upgraded Regal Beloit Corp (NYSE: RBC) from Perform to Outperform. Regal Beloit shares gained 0.06 percent to close at $78.75 on Thursday.
  • JP Morgan upgraded Scripps Networks Interactive, Inc. (NASDAQ: SNI) from Neutral to Overweight. Scripps Networks shares rose 2.63 percent to close at $70.20 on Thursday.


Top Downgrades

  • Wells Fargo downgraded U.S. Bancorp (NYSE: USB) from Outperform to Market Perform. US Bancorp shares rose 0.19 percent to close at $52.31 on Thursday.
  • Baird downgraded Akamai Technologies, Inc. (NASDAQ: AKAM) from Outperform to Neutral. Akamai Technologies shares fell 0.28 percent to $52.71 in pre-market trading.
  • Goldman Sachs downgraded Yum China Holdings Inc (NYSE: YUMC) from Buy to Neutral. Yum China shares dropped 1.65 percent to close at $34.50 on Thursday.
  • Analysts at FBR Capital downgraded National CineMedia, Inc. (NASDAQ: NCMI) from Outperform to Market Perform. National CineMedia shares dropped 1.51 percent to close at $11.72 on Thursday.
  • Jefferies downgraded MAXIMUS, Inc. (NYSE: MMS) from Buy to Hold. Maximus shares gained 2.85 percent to close at $61.39 on Thursday.
  • JMP Securities downgraded Kennedy-Wilson Holdings Inc (NYSE: KW) from Market Outperform to Market Perform. Kennedy-Wilson shares gained 0.74 percent to close at $20.40 on Thursday.
  • Societe Generale downgraded Estee Lauder Companies Inc (NYSE: EL) from Buy to Hold. Estee Lauder shares rose 0.61 percent to close at $91.86 on Thursday.
  • Analysts at Baird downgraded Stericycle Inc (NASDAQ: SRCL) from Neutral to Underperform. Stericycle shares rose 1.28 percent to $86.83 in pre-market trading.
  • Argus Research downgraded Celgene Corporation (NASDAQ: CELG) from Buy to Hold. Celgene shares fell 0.48 percent to $123.86 in pre-market trading.
  • Morgan Stanley downgraded Choice Hotels International Inc (NYSE: CHH) from Overweight to Equal-Weight. Choice Hotels shares gained 1.85 percent to close at $66.10 on Thursday.


Top Initiations

  • Analysts at BMO Capital initiated coverage of Coherus Biosciences Inc (NASDAQ: CHRS) with an Outperform rating. The price target for Coherus Biosciences is set to $54. Coherus Biosciences shares closed at $19.30 on Thursday.
  • Analysts at UBS initiated coverage on Alder Biopharmaceuticals Inc (NASDAQ: ALDR) with a Sell rating. The price target for Alder Biopharmaceuticals is set to $13. Alder Biopharmaceuticals shares closed at $21.80 on Thursday.
  • Analysts at Cantor Fitzgerald initiated coverage on Versartis Inc (NASDAQ: VSAR) with an Overweight rating. The price target for Versartis is set to $34. Versartis shares closed at $17.05 on Thursday.
  • Analysts at Bank of America initiated coverage on Neurocrine Biosciences, Inc. (NASDAQ: NBIX) with a Buy rating. The price target for Neurocrine Biosciences is set to $70. Neurocrine Biosciences shares closed at $53.63 on Thursday.
  • Analysts at Citi initiated coverage on Playa Hotels & Resorts NV (NASDAQ: PLYA) with a Neutral rating. Playa Hotels shares closed at $10.16 on Thursday.

Latest Ratings for ZNGA

DateFirmActionFromTo
Nov 2019MaintainsBuy
Sep 2019AssumesNeutral
Aug 2019MaintainsOutperform

View More Analyst Ratings for ZNGA
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (AKAM + ALDR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ROSTMKM PartnersMaintains121.0
STAYNomuraDowngrades15.0
ROKUMacquarieMaintains170.0
BJDeutsche BankMaintains27.0
MDeutsche BankMaintains18.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

With Media Trends Unlikely To Improve, Baird Downgrades Akamai

The Latest In The Shoe Sector: German Brands Kick Off Industry Growth